About: http://data.cimple.eu/news-article/b0d57d38f9fbb5d40a7512936d8790d0fa3fe8cdfc8823b26643885c     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • India announced Tuesday a partial lifting of a fresh export ban on a malaria drug seen as a potential coronavirus treatment, after US President Donald Trump hinted at "retaliation". Citing domestic needs, India banned on Saturday exports of hydroxychloroquine which has shown early promise against COVID-19 in small-scale studies in France and China. India is the world's largest producer and exporter of the drug, according to media reports. Global stocks are however limited and Trump said that he had pressed Indian Prime Minister Narendra Modi this weekend to expedite shipments, hinting at consequences otherwise. "If he doesn't allow it to come out, he doesn't allow it to come out, that would be okay, but of course, there may be retaliation, why wouldn't there be?" Trump said on Monday. The Indian foreign ministry swiftly backtracked and on Tuesday said it would now license the export of the drug and paracetamol -- exports of which were restricted in March -- "in appropriate quantities to all our neighbouring countries who are dependent on our capabilities." "We will also be supplying these essential drugs to some nations who have been particularly badly affected by the pandemic," foreign ministry spokesman Anurag Srivastava said in a statement. He added that they would be "kept in a licensed category and... continuously monitored." Trump has strongly touted hydroxychloroquine as a coronavirus treatment although many scientists are urging caution until larger trials show whether it is safe and effective. Hydroxychloroquine and another drug, chloroquine, have been used for decades against malaria but they have potentially serious side effects, especially in high doses or administered with other medications. The European Medicine Agency warned last week that the two drugs should not be used to treat COVID-19 cases, except for clinical trials or in the event of a "national emergency". The Times of India reported that New Delhi had also come under pressure from Australian Prime Minister Scott Morrison and from other countries including Britain, France, Germany and Brazil over pharma exports. stu/ecl
schema:headline
  • India eases malaria drug export ban after Trump threat
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...entionsConspiracy
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software